Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
NCT03699176
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
No patient was recruited, study withdrawn for feasibility reasons.
Conditions
Uterine Fibroids
Interventions
DRUG:
Vilaprisan (BAY1002670)
DRUG:
Placebo
Sponsor
Bayer